ZA962479B - A multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose - Google Patents

A multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose

Info

Publication number
ZA962479B
ZA962479B ZA962479A ZA962479A ZA962479B ZA 962479 B ZA962479 B ZA 962479B ZA 962479 A ZA962479 A ZA 962479A ZA 962479 A ZA962479 A ZA 962479A ZA 962479 B ZA962479 B ZA 962479B
Authority
ZA
South Africa
Prior art keywords
clostridial
low dose
organisms
vaccine containing
multicomponent vaccine
Prior art date
Application number
ZA962479A
Other languages
English (en)
Inventor
Richard E Parizek
Lonny E Vlieger
Sharon A Bryant
Stuart K Nibbelink
Michael J Mcginley
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23633975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA962479(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA962479B publication Critical patent/ZA962479B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA962479A 1995-03-29 1996-03-28 A multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose ZA962479B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/412,676 US6743430B1 (en) 1995-03-29 1995-03-29 Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose

Publications (1)

Publication Number Publication Date
ZA962479B true ZA962479B (en) 1996-10-03

Family

ID=23633975

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962479A ZA962479B (en) 1995-03-29 1996-03-28 A multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose

Country Status (11)

Country Link
US (3) US6743430B1 (de)
EP (1) EP0734731B1 (de)
AR (1) AR002725A1 (de)
AU (1) AU708878B2 (de)
BR (1) BR9601193A (de)
CA (1) CA2172180C (de)
DE (1) DE69636001T2 (de)
ES (1) ES2262147T3 (de)
HU (1) HUP9600781A3 (de)
PT (1) PT734731E (de)
ZA (1) ZA962479B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
BR9803232A (pt) 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
FR2768747B1 (fr) * 1997-09-19 2000-12-01 Pasteur Institut Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
EP0924295A3 (de) * 1997-12-04 2001-05-16 Pfizer Products Inc. DNS kodierend für Neospora Dihydrofolatreductase-Thymidylate Synthase
WO2007126816A2 (en) * 2006-03-30 2007-11-08 Embrex, Inc. Methods and compositions for vaccination of poultry
WO2011044576A2 (en) * 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
PT2493498T (pt) 2009-10-30 2017-05-24 Glaxosmithkline Biologicals Sa Purificação de sacáridos capsulares de staphylococcus aureus tipo 5 e tipo 8
AR086199A1 (es) 2011-04-22 2013-11-27 Wyeth Llc Composiciones relacionadas con una toxina de clostridium difficile mutante y sus metodos
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
WO2021255690A2 (en) 2020-06-19 2021-12-23 Pfizer Inc. Immunogenic compositions against clostridioides (clostridium) difficile and methods thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US3925544A (en) 1971-07-12 1975-12-09 Univ Southern Illinois Bovine vaccines and methods of making and using same
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
SU627612A1 (ru) 1977-09-30 1980-02-05 Zemlyakova V P Препарат земл ковой в.п. против клюстридиозов животных и птиц
NZ193807A (en) 1979-05-31 1983-03-15 Ici Tasman Ltd Improving the response of ruminants to clostridial vaccine by administering tetramisole or levamisole
PT692974E (pt) * 1993-03-29 2003-09-30 Pfizer Vacinas clostridiais com multiplos componentes usando adjuvantes de saponina
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose

Also Published As

Publication number Publication date
US20100111997A1 (en) 2010-05-06
ES2262147T3 (es) 2006-11-16
HUP9600781A2 (en) 1996-12-30
PT734731E (pt) 2006-07-31
EP0734731A3 (de) 1998-03-11
EP0734731B1 (de) 2006-04-05
CA2172180C (en) 2012-02-21
DE69636001D1 (de) 2006-05-18
EP0734731A2 (de) 1996-10-02
US6743430B1 (en) 2004-06-01
HU9600781D0 (en) 1996-05-28
US20040141986A1 (en) 2004-07-22
AU4825996A (en) 1996-10-10
DE69636001T2 (de) 2006-10-26
HUP9600781A3 (en) 2002-05-28
AR002725A1 (es) 1998-04-29
AU708878B2 (en) 1999-08-12
BR9601193A (pt) 1998-01-06
CA2172180A1 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
EP0728014A4 (de) In pflanzen exprimierte impfstoffe
GR3033532T3 (en) Multi-digit drum-counter for use in a flow-meter.
AU7789194A (en) Improvements in and relating to vaccines
ZA9810882B (en) A medicament in soft pellet form and processes therefor
GB9114792D0 (en) Comminution in a planetary mill
EP0732396A4 (de) Mikrooorganismus und Deodorant entsprechende Zellen enthaltend
HUP9600781A2 (en) A multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
AU7216996A (en) A paf-acetylhydrolase and use in therapy
GB2312666B (en) A spacer tray and bottle combination
ZA944779B (en) Cosmetic composition containing in combination a super-oxide-dismutase and a melanin pigment
HUP9900321A3 (en) A plastic bag dispenser and a plastic bag for use in said dispenser
IL112391A0 (en) A medicament in dosage unit form
GB9322010D0 (en) A bicomponent tissue and seedling culture bottle
AU644996B3 (en) Improvements in coinfreed amusement machines
GB9400241D0 (en) A Collection and delivery system
EP0612131A3 (de) Verbesserungen an und betreffend Schalter.
PH30808A (en) 2-Amino-4-heteroaryl-1,-4-2dihydropyridines and their use in medicaments.
AU5102096A (en) Novel 1,3-dioxane and its use in perfumery
GB9521034D0 (en) Improvemts in and relating cartons
ZA917690B (en) A micro-organism and proteases therefrom
HU9400232D0 (en) Produce of a new bacillus strain, the new strain and the use of such strain in a fermentation
AU2868389A (en) Improvements in or relating to a dispenser and a dispenser system
GB2278224B (en) Improvements in and relating to signage
GB9315924D0 (en) Message in a bottle
GB9324140D0 (en) Improvements in and relating to dispensers